Compare RAND & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAND | COSM |
|---|---|---|
| Founded | 1969 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6M | 27.9M |
| IPO Year | 1996 | 2009 |
| Metric | RAND | COSM |
|---|---|---|
| Price | $10.65 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 2.5M |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | ★ 10.83% | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ 0.34 | N/A |
| Revenue | N/A | ★ $65,271,815.00 |
| Revenue This Year | N/A | $54.08 |
| Revenue Next Year | N/A | $32.66 |
| P/E Ratio | $31.32 | ★ N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $10.00 | $0.16 |
| 52 Week High | $17.49 | $1.32 |
| Indicator | RAND | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 51.01 | 73.02 |
| Support Level | $10.58 | $0.29 |
| Resistance Level | $11.31 | $0.35 |
| Average True Range (ATR) | 0.27 | 0.03 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 37.11 | 94.73 |
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. Its investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.